{"filing":{"accession_number":"0001104659-26-107117","cik":"0002020932","ticker":"AGMB","company_name":"Agomab Therapeutics NV","form":"6-K","filing_date":"2026-09-11","report_date":"2026-09-11","primary_document":"tm2625311d1_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2020932/000110465926107117/tm2625311d1_6k.htm"},"events":[{"id":33016,"run_id":30347,"accession_number":"0001104659-26-107117","anchor_item_number":"EX-99.1","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The exhibit announces shareholder approval of the appointments of Marino Garcia and Dr. Naimish Patel as non-executive members of Agomab's Board of Directors at the Company's Special and Extraordinary General Shareholders' Meeting on September 11, 2026. This is a discrete executive appointment event requiring disclosure under Item 5.02 of Form 8-K (or equivalent 6-K disclosure). Board appointments are material to investors as they affect governance and strategic direction.","company_name":"Agomab Therapeutics NV","ticker":"AGMB","filing_date":"2026-09-11","form":"6-K","submitted_at":null,"items":[{"id":36341,"accession_number":"0001104659-26-107117","item_number":"EX-99.1","item_title":"tm2625311d1_ex99-1.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The exhibit announces shareholder approval of the appointments of Marino Garcia and Dr. Naimish Patel as non-executive members of Agomab's Board of Directors at the Company's Special and Extraordinary General Shareholders' Meeting on September 11, 2026. This is a discrete executive appointment event requiring disclosure under Item 5.02 of Form 8-K (or equivalent 6-K disclosure). Board appointments are material to investors as they affect governance and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-11T21:03:37.457592+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36341,"accession_number":"0001104659-26-107117","item_number":"EX-99.1","item_title":"tm2625311d1_ex99-1.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The exhibit announces shareholder approval of the appointments of Marino Garcia and Dr. Naimish Patel as non-executive members of Agomab's Board of Directors at the Company's Special and Extraordinary General Shareholders' Meeting on September 11, 2026. This is a discrete executive appointment event requiring disclosure under Item 5.02 of Form 8-K (or equivalent 6-K disclosure). Board appointments are material to investors as they affect governance and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-11T21:03:37.457592+00:00","company_name":"Agomab Therapeutics NV","ticker":"AGMB","filing_date":"2026-09-11"}]}